MOTS-c (Mitochondrial Peptide)

MOTS-c Storage, Stability and Reconstitution

UKPWritten and published by UK Peptides2 min readUpdated 2 cited sources

The short answer

MOTS-c is supplied lyophilised and is most stable in that state, stored cold, dry and protected from light. Its two methionine residues oxidise readily, which is the principal degradation route. In solution stability falls substantially, and repeated freeze-thaw cycles should be avoided by aliquoting.

Key facts

Supplied as
White lyophilised powder
Main degradation route
Methionine oxidation (+16 Da per residue)
Oxidation-prone residues
Met1, Met6
Disulfide risk
None (no cysteine)
Lyophilised storage
Cold, dry, dark
In solution
Markedly less stable than lyophilised
Freeze-thaw
Avoid by aliquoting

Why the lyophilised form is stable

Freeze-drying removes water, and water is a participant in peptide-bond hydrolysis. A dry powder held cold has very limited routes to degrade. This is why peptides are shipped and stored lyophilised rather than in solution, and why the powder's condition on arrival matters. Material that has been through a warm transit has spent that time in a less protected state.

The specific vulnerability: methionine

MOTS-c has methionine at positions 1 and 6. The thioether sulfur in methionine oxidises to the sulfoxide readily in the presence of dissolved oxygen, and the reaction is accelerated by light and by temperature. Each oxidation adds 16 Da, so oxidised material appears as +16 and +32 satellites on a mass spectrum. This is the single most likely way a MOTS-c sample degrades, and it is why dark, cold, dry storage is not generic advice for this peptide but a specific response to its sequence.

Research material referenced

MOTS-C 10mg, third-party HPLC tested

Buy MOTS-C · £24.99

What the absence of cysteine simplifies

With no cysteine there is no disulfide chemistry to manage. Peptides containing free thiols can dimerise or scramble intramolecular bonds, and often need reducing agents in buffer. None of that applies here, which makes MOTS-c handling simpler than its length would suggest.

Reconstitution

Bacteriostatic water (sterile water preserved with 0.9% benzyl alcohol) is the usual diluent for research peptides, because it permits repeated entry into the same vial over a limited window. Solvent should be introduced gently against the vial wall rather than directed onto the powder, and the vial swirled rather than shaken. Vigorous agitation generates an air-liquid interface, and peptides denature at that interface; foaming is a visible sign that it has happened.

Once in solution

Solution-phase material is subject to both hydrolysis and oxidation, and stability falls accordingly. Aliquoting into single-use volumes avoids repeated freeze-thaw cycling, which is independently damaging: each cycle concentrates solutes at the ice boundary and exposes the peptide to interfaces it does not tolerate well.

Signs of a problem

Visible particulates, cloudiness or discolouration in a reconstituted solution indicate something has gone wrong and the material should not be relied on for a measurement. A peptide that will not go into solution at a concentration it previously tolerated is also a signal, commonly of aggregation.

Frequently asked questions

Why is MOTS-c particularly sensitive to light and air?

Its two methionine residues oxidise to the sulfoxide in the presence of oxygen, and light and heat accelerate the reaction. Most 16-mers without methionine are less demanding.

Does MOTS-c need a reducing agent in buffer?

No. Reducing agents address disulfide chemistry, and MOTS-c has no cysteine.

Why avoid shaking the vial?

Shaking creates an air-liquid interface where peptides denature. Foam is the visible evidence. Swirl instead.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More MOTS-c (Mitochondrial Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.